{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:44:13Z","timestamp":1790257453122,"version":"4.1.0"},"reference-count":21,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.3892\/ol.2016.4624","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T08:32:25Z","timestamp":1464165145000},"page":"387-392","source":"Crossref","is-referenced-by-count":6,"title":["Efficiency of AUY922 in mice with adult T-cell leukemia\/lymphoma"],"prefix":"10.3892","volume":"12","author":[{"given":"CHIE","family":"ISHIKAWA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASACHIKA","family":"SENBA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NAOKI","family":"MORI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"key":"key20180108111906_b1-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108111906_b2-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108111906_b3-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.79.6.2031","article-title":"Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease","volume":"79","author":"Yoshida","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108111906_b4-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1182\/blood-2011-03-345702","article-title":"How I treat adult T-cell leukemia\/lymphoma","volume":"118","author":"Bazarbachi","year":"2011","journal-title":"Blood"},{"key":"key20180108111906_b5-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20180108111906_b6-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1078-0432.CCR-08-0132","article-title":"Heat shock protein 90 as a drug target: Some like it hot","volume":"15","author":"Banerji","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180108111906_b7-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ctrv.2012.10.001","article-title":"Targeting the molecular chaperone heat shock protein 90 (HSP90): Lessons learned and future directions","volume":"39","author":"Hong","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"key20180108111906_b8-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4161\/auto.4761","article-title":"Targeting autophagic regulation of NFkappaB in HTLV-I transformed cells by geldanamycin: Implications for therapeutic interventions","volume":"3","author":"Yan","year":"2007","journal-title":"Autophagy"},{"key":"key20180108111906_b9-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canlet.2009.04.012","article-title":"Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin\/TCF7L2 pathway in adult T cell leukemia cells","volume":"284","author":"Kurashina","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180108111906_b10-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/bcj.2013.30","article-title":"Oral administration of an HSP90 inhibitor, 17-DMAG, intervenes tumor-cell infiltration into multiple organs and improves survival period for ATL model mice","volume":"3","author":"Ikebe","year":"2013","journal-title":"Blood Cancer J"},{"key":"key20180108111906_b11-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1200\/JCO.2005.00.612","article-title":"Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies","volume":"23","author":"Banerji","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180108111906_b12-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1200\/JCO.2009.25.0415","article-title":"Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors","volume":"28","author":"Ramanathan","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180108111906_b13-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/jnci\/91.22.1940","article-title":"DT-diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90","volume":"91","author":"Kelland","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"key20180108111906_b14-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1158\/0008-5472.CAN-07-5256","article-title":"NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis","volume":"68","author":"Eccles","year":"2008","journal-title":"Cancer Res"},{"key":"key20180108111906_b15-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/bcr1996","article-title":"NVP-AUY922: A small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models","volume":"10","author":"Jensen","year":"2008","journal-title":"Breast Cancer Res"},{"key":"key20180108111906_b16-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X","article-title":"Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia","volume":"73","author":"Kamihira","year":"1994","journal-title":"Cancer"},{"key":"key20180108111906_b17-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1349-7006.2005.00106.x","article-title":"Serum level of soluble CD30 correlates with the aggressiveness of adult T-cell leukemia\/lymphoma","volume":"96","author":"Nishioka","year":"2005","journal-title":"Cancer Sci"},{"key":"key20180108111906_b18-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1158\/1078-0432.CCR-06-2966","article-title":"Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells","volume":"13","author":"Xu","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180108111906_b19-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/cas.12540","article-title":"Heat shock protein 90 inhibitor NVP-AUY922 exerts potent activity against adult T-cell leukemia-lymphoma cells","volume":"105","author":"Taniguchi","year":"2014","journal-title":"Cancer Sci"},{"key":"key20180108111906_b20-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1158\/1078-0432.CCR-12-3404","article-title":"First-in-human phase I dose-escalation study of the HSP90 inhibitor AUY922 in patients with advanced solid tumors","volume":"19","author":"Sessa","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20180108111906_b21-ol-0-0-4624","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00280-014-2521-x","article-title":"Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors","volume":"74","author":"Doi","year":"2014","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4624\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T15:26:03Z","timestamp":1515425163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,25]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,25]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.3892\/ol.2016.4624"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4624","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,25]]}}}